Caroline Palm Apergi
Researcher
E-mail: caroline.palm.apergi@ki.se
Telephone: +46852483590
Visiting address: Nobels väg 7, 17165 Solna
Postal address: H5 Laboratoriemedicin, H5 BCM, 141 52 Huddinge
Part of:
Articles
-
Article: BLOOD CANCER JOURNAL. 2023;13(1):139
-
Article: METHODS IN MOLECULAR BIOLOGY. 2022;2383:257-264
-
Article: FASEB JOURNAL. 2021;35(7):e21741
-
Article: FASEB JOURNAL. 2021;35(5):e21476
-
Journal article: CLINICAL LYMPHOMA MYELOMA & LEUKEMIA. 2020;20:s163
-
Article: SCIENTIFIC REPORTS. 2020;10(1):2688
-
Article: SCIENTIFIC REPORTS. 2019;9(1):536
-
Article: METHODS IN MOLECULAR BIOLOGY. 2019;2036:53-72
-
Article: NUCLEIC ACID THERAPEUTICS. 2017;27(5):260-271
-
Article: JOURNAL OF CONTROLLED RELEASE. 2017;261:199-206
-
Article: PLOS ONE. 2017;12(6):e0178844
-
Article: NATURE BIOTECHNOLOGY. 2014;32(12):1256-1261
-
Article: NATURE COMMUNICATIONS. 2011;2:453
-
Article: METHODS IN MOLECULAR BIOLOGY. 2011;683:339-347
-
Article: METHODS IN MOLECULAR BIOLOGY. 2011;683:157-164
-
Article: FASEB JOURNAL. 2009;23(1):214-223
-
Article: JOURNAL OF CONTROLLED RELEASE. 2008;132(1):49-54
-
Article: BIOCHIMICA ET BIOPHYSICA ACTA: INTERNATIONAL JOURNAL OF BIOCHEMISTRY AND BIOPHYSICS. 2007;1768(7):1769-1776
-
Article: PEPTIDES. 2006;27(7):1710-1716
All other publications
-
Editorial comment: BLOOD. 2023;142(23):1941-1942
-
Editorial comment: FUTURE MEDICINAL CHEMISTRY. 2020;12(16):1457-1460
-
Conference publication: CLINICAL LYMPHOMA MYELOMA & LEUKEMIA. 2020;20:S163
-
Review: ONCOGENE. 2019;38(1):1-16
-
Editorial comment: MOLECULAR THERAPY. 2012;20(4):695-697